UNLOCKING
POTENTIAL
about
Business concept
Kintaro Cells Power continues to develop its business not only in Asia but also around the world. As a result, we plan to establish new production facilities overseas that comply with the international Good Manufacturing Practice (GMP) standard for production control and quality control of pharmaceuticals and quasi-drugs.
In Japan, we plan to promote drug discovery in cooperation with organizations meeting the GCTP (Good Gene, Cellular, and Tissue-based Products manufacturing practice) standards for practices that include production control and quality control of regenerative medicine. The manufacturing and development of «KINTARO Cells®» is an amalgamation of advanced biotechnological achievements from Russia and Japan. Our laboratories have accumulated over 50 years of research and development experience in addition to more than 7,000 clinical trials and treatments. «KINTARO Cells®» takes advantage of existing advanced biotechnological applications in Japan by continuing collaborative research with Tokyo Medical University.
key members
Alexei Gladkov
President
1989: Received a Master of Philosophy degree from Novosibirsk University.
2002: Received a Master of Business Administration degree in Moscow. With over 28 years of international business experience, 22 years were actively based in Japan. This included the experience in international medical tourism, internet and software development, biotechnology-related work, and other fields.
2010: Personally underwent bone marrow-derived mesenchymal stem cell therapy and recognized its positive potential.
2014: Established Kintaro Cells Power Co., Ltd. in Japan based on advanced cell cultivation technology.
about
companies group
Through accurate cooperation within the companies group, we deliver healthy longevity and happiness to countries around the world.
KINTARO Cells Power
The company conducts research and development using «KINTARO Cells®», which are bone marrow-derived mesenchymal stem cells, extracted and cultured using cutting-edge biotechnology.
Representative Director
Gladkov Alexei
Head Office
1-18-1 Takanawa, Minato-ku, Tokyo 108-0074
KINTARO Bio Development
The company is in charge of optimal promotion materials, global strategy, development of research and culture facilities, and a comprehensive branding strategy related to «KINTARO Cells®».
Representative Director
Gladkov Alexei
Head Office
1-18-1 Takanawa, Minato-ku, Tokyo 108-0074
KINTARO VIP
This company is a local subsidiary located in Singapore. It works at popularizing «KINTARO Cells®», mainly in Singapore and Malaysia.
Representative Director
Go Xiong Hai
Head Office
4 Shenton Way #28-01 SGX center 2 Singapore, 068807
KINTARO Sun Power
The company is responsible for planning and promoting various research projects in cooperation with medical universities and research institutions.
Representative Director
Yoji Owari
Head Office
1-406 Oshoro, Otaru, Hokkaido 048-2561
KINTARO Okinawa
Okinawa is a national strategic special zone designed to revitalize the local economy. Taking advantage of these characteristics, the company aims at constructing the KINTARO Robot Factory and conducting research into stem cell conditional medium.
Representative Director and Chairman
Gladkov Alexei
Head Office
Yukari Naha, 211-1 Mekaru, Naha City, Okinawa 900-0004
show more
goal
cell culture cultivation
In order to reduce manufacturing and labor costs, we plan to implement fully automated cultivation. By taking the human factor out of the equation, we can greatly reduce the risks of contamination, significantly save on manual labor costs, and significantly reduce the local production setup time.
1st stage
Semi-automated cell cultivation
Our first goal is to design a semi-automated product, which will be operated by a trained technician through a microscope and a simple control interface. The first year involves taking designs, applying for patents, and organizing the technical development team.
2nd stage
Fully automated cell cultivation
New equipment will be designed so that it can be easily operated by anyone and can avoid the requirement of a CPC laboratory with immense installation and running costs. Our goal is expanding this product into the biotechnology market.
3rd stage
Control by AI
This stage consists of the development of an automated cultivation device: AI software and advanced equipment, that can perform automatic cell analysis. With fully automatic control by AI, «KINTARO Cells®» will be manufactured in the best conditions without risk of human errors.